63400 A randomized phase 2 proof-of-concept study to evaluate the efficacy and safety of topical bimiralisib application in patients suffering from actinic keratosis on the face and/or scalp and/or back of hands over a 2 and 4-week treatment period - 01/09/25
Doi : 10.1016/j.jaad.2025.05.432
Il testo completo di questo articolo è disponibile in PDF.
| Commercial Disclosure: The study was fully funded by Torqur AG, covering all (100% of) research-related expenses. However, the sponsor did not provide any financial support for attending the AAD meeting, presenting the poster, or sharing the research data at the conference. |
© 2025
Pubblicato da Elsevier Masson SAS.
Vol 93 - N° 3S
P. AB108 - settembre 2025 Ritorno al numero
Articolo precedente
- 60053 A Quality Improvement Project to Identify and Improve the Skin Cancer Diagnostic Gap in Veterans Aged 70 and Older
- Kevin Gale, Danielle Murray, Joseph Guinness, Justin Endo
- 64388 A randomized study to evaluate the efficacy and adverse effects of oral Tofacitinib, oral Methotrexate and Intramuscular Methotrexate in moderate to severe Palmoplantar Psoriasis
- ananditha kopparthy, Pallavi Sai Adapa
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?